Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (251-260 of 258) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 258 results.
Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Nature Medicine|April 15, 2025
Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Nature Medicine|April 1, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 26

Showing results (251-260 of 258) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Nature Medicine|April 15, 2025
Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Nature Medicine|April 1, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 26